Medicare Enrolled
Dr. Ilona Genis, MD
Ophthalmology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Genis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Genis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Genis
Dr. Ilona Genis is an ophthalmology specialist in Brooklyn, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Genis performed 13,820 Medicare services across 8,924 unique beneficiaries.
Between the years covered by Open Payments, Dr. Genis received a total of $7,702 from 36 pharmaceutical and/or device companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Genis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 5% volume in NY
$7,702 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,820
Medicare services
Top 5% in NY for ophthalmology
8,924
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~658 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,338 | $82 | $107 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
1,630 | $56 | $74 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,435 | $33 | $44 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
1,207 | $33 | $43 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
931 | $36 | $48 |
| Ultrasound of eye using water bath method An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures. |
751 | $132 | $173 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
625 | $53 | $68 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
560 | $105 | $135 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
555 | $114 | $148 |
| Aflibercept eye injection (Eylea) | 524 | $692 | $886 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
399 | $204 | $341 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
322 | $59 | $77 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
300 | $34 | $46 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
293 | $137 | $174 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
284 | $42 | $55 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
232 | $122 | $153 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
218 | $41 | $55 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
157 | $424 | $638 |
| Eye photography Photographic imaging of the interior structures of the eye. |
141 | $21 | $29 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
101 | $31 | $43 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
89 | $64 | $80 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
87 | $17 | $22 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
66 | $781 | $980 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
65 | $312 | $397 |
| Ultrasound scan to determine eye length and lens power An ultrasound procedure used to measure the length of the eye and calculate the power of the lens. |
50 | $28 | $79 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
49 | $607 | $873 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $121 | $151 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
46 | $228 | $291 |
| Eyelid growth removal A procedure to remove a growth from the eyelid. |
42 | $265 | $349 |
| Amniotic membrane placement on eye surface This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing. |
39 | $1,303 | $1,626 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
38 | $78 | $105 |
| Contact lens fitting for eye surface disease This procedure involves the fitting of a contact lens specifically intended to treat or manage a disease affecting the surface of the eye. |
31 | $33 | $43 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
28 | $280 | $357 |
| Eye wound repair or revision Surgical repair or revision of an operative wound on the eye. |
25 | $633 | $901 |
| Insertion of probe into nasal tear duct | 20 | $228 | $367 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
19 | $132 | $165 |
| Removal of chronic eyelid growth This procedure involves the surgical removal of a long-standing growth on the eyelid. |
18 | $122 | $154 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
15 | $26 | $32 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
15 | $14 | $18 |
| Eye deviation and range of motion exam An examination to measure eye deviation and assess the range of motion of the eyes. |
14 | $54 | $74 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
12 | $72 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
34.4% medium
64.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,702
Total received (2018-2024)
Avg $1,100/year across 7 years
Top 13% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
345
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,702 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,289
2023
$1,303
2022
$673
2021
$1,166
2020
$1,076
2019
$1,119
2018
$1,076
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Harrow Eye, LLC
$246
Bausch & Lomb Americas Inc.
$234
Alcon Vision LLC
$186
ABBVIE INC.
$146
Tarsus Pharmaceuticals, Inc.
$115
Oyster Point Pharma, Inc.
$89
Amgen Inc.
$64
Apellis Pharmaceuticals, Inc.
$57
Thea Pharma Inc.
$48
Regeneron Healthcare Solutions, Inc.
$33
Astellas Pharma US Inc
$32
BIOTISSUE HOLDINGS INC.
$23
Dompe US, Inc.
$18
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,142
Allergan, Inc.
$743
Bausch & Lomb, a division of Bausch Health US, LLC
$702
Alcon Vision LLC
$563
NEW WORLD MEDICAL,INC.
$457
Bausch & Lomb Americas Inc.
$455
ABBVIE INC.
$452
Sun Pharmaceutical Industries Inc.
$369
Allergan Inc.
$254
Harrow Eye, LLC
$246
Aerie Pharmaceuticals, Inc.
$237
Oyster Point Pharma, Inc.
$236
Shire North American Group Inc
$210
Regeneron Healthcare Solutions, Inc.
$164
Eyevance Pharmaceuticals LLC
$155
Kala Pharmaceuticals, Inc.
$147
Akorn Operating Company LLC
$130
Mallinckrodt Hospital Products Inc.
$124
Horizon Therapeutics plc
$123
Tarsus Pharmaceuticals, Inc.
$115
BIOTISSUE HOLDINGS, INC.
$74
Thea Pharma Inc.
$70
Amgen Inc.
$64
Sight Sciences, Inc.
$63
Apellis Pharmaceuticals, Inc.
$57
Dompe US, Inc.
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
EYEVANCE PHARMACEUTICALS LLC
$43
Akorn, Inc.
$40
Johnson & Johnson Surgical Vision, Inc.
$36
Astellas Pharma US Inc
$32
Alcon Laboratories Inc
$23
BIOTISSUE HOLDINGS INC.
$23
BioTissue Holdings, Inc.
$21
TISSUETECH, INC.
$20
Carl Zeiss Meditec AG
$19
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ALREX · ARGOS · AcrySof · Ahmed Glaucoma Valve · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · Clareon · DUREZOL · DURYSTA · EYLEA · EYLEA HD · Flarex · ILEVRO · INVELTYS · IYUZEH · Izervay · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PAZEO · PROKERA · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis Simplicity · Tobradex ST · VEVYE · VUITY · VYZULTA · XDEMVY · XIIDRA · Zerviate · Zioptan · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
1,246
Per 100K population
47.1
County median income
$78,548
Nearest hospital
SOUTH BROOKLYN HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Genis is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement in the top 13% of NY peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Genis experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Genis performed 2,338 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Genis receive payments from pharmaceutical companies?
Yes. Dr. Genis received a total of $7,702 from 36 companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Genis's costs compare to other ophthalmologists in Brooklyn?
Dr. Genis's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Genis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Brooklyn
Browse ophthalmologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NY
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NY
Which NY ophthalmologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology